MRK vs SYK
By Alex · Tickerpine
Merck & Company, Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | SYK |
|---|---|---|
| Price | $132.92 | $347.21 |
| Market cap | $327.94B | $133.18B |
| P/E ratio | 106.3 | 36.1 |
| ROE | 6.96% | 16.51% |
| Profit margin | 4.77% | 14.43% |
| Revenue growth | 5.10% | 9.40% |
| Dividend yield | 2.56% | 1.01% |
| Beta | 0.21 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs SYK in plain English
- MRK is the bigger company — about 2.5× the market cap of SYK.
- SYK is cheaper on earnings (P/E 36.1 vs 106.3).
- SYK earns a higher return on equity (17% vs 7%).
- SYK is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.56% vs 1.01%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.